Sab Biotherapeutics Inc Share Price

NASDAQ: SABS

Small Cap

$2.58

+0.43

(+20.00%)

as on September 18, 2025 at 1:29 am IST

$₹

Sab Biotherapeutics Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$2.19
Day's Price Range
$2.63
$2.58
15.12%
Downside
1.94%
Upside
52 Week's Low
52 Week's High
$1
52-Week Price Range
$6.6
$2.58
61.24%
Downside
155.81%
Upside

Sab Biotherapeutics Inc share price movements today

Previous Close: $2.15
Open: $2.20
Volume: 807.0K
Day's Low - High: $2.19 - $2.63
52 Week Low - High: $1 - $6.6

Sab Biotherapeutics Inc Historical Returns

1 Month Return: -3.15 %
3 Month Return: + 20.79 %
1 Year Return: -22.38 %
3 Year Return: -75 %
5 Year Return: 0 %

Sab Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Sab Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$21.9M

EPS (TTM)

-2.206

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.60%

PE Ratio (TTM)

-0.66

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-38.5M

Revenue (TTM)

114.7K

Profit Margin

0.00%

Return On Equity TTM

36852100.00%

Sab Biotherapeutics Inc Stock Valuation

Track how Sab Biotherapeutics Inc P/E has moved over time to understand its valuation trends.

Sab Biotherapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (-0.66x)

September 17, 2025

Highest (-0.44x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.66x

Sab Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sab Biotherapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Sab Biotherapeutics Inc	BUY	$21.9M	NA	-0.66	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Stock Returns calculator for Sab Biotherapeutics Inc Stock including INR - Dollar returns

The Sab Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Sab Biotherapeutics Inc investment value today

Current value as on today

₹97,739

Returns

₹2,261

(-2.26%)

Returns from Sab Biotherapeutics Inc Stock

₹6,859 (-6.86%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Sab Biotherapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Sab Biotherapeutics Inc. Average target price of $9.2

Sab Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Sab Biotherapeutics Inc.

What analysts predicted

71.96%UPSIDE

Target Price

$9.2

Current Price

$2.58

Analyzed by

8 Analysts

Target

$9.20

Sab Biotherapeutics Inc target price $9.2, a slight upside of 71.96% compared to current price of $2.58. According to 8 analysts rating.

Sab Biotherapeutics Inc Stock's Interest Amongst Investors

Search interest for Sab Biotherapeutics Inc Stock has decreased by -89% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-89% versus previous 30 day period

Sab Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	2	0	1	0	0	0	0	0	-	-
Gross Profit	1	0	0	0	-1	0	-1	0	0	0
Operating Income	-7	-6	-5	-18	-11	-10	-11	-10	-10	-9
EBITDA	-6	-5	-4	-21	-2	-6	-9	-10	-4	-9
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	1	1	0	0	0	0
Income Before Tax	-7	-6	-5	-22	-5	-7	-10	-11	-5	-10
Income Tax Expense	0	0	0	0	-13	-	-	13	-	-
Net Income	-7	-6	-5	-22	-5	-7	-10	-11	-5	-10
Net Profit Margin	-340.31%	-8046.26%	-402.68%	-7493.83%	-532.09%	-2787.52%	2524146.34%	-9934.79%	0.00%	0.00%

Sab Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	3	55	60	23	2	1
Gross Profit	3	55	59	20	-1	-3
Operating Income	-8	20	-13	-28	-38	-42
EBITDA	-8	21	-15	-15	-38	-28
Interest Expense	0	0	0	0	0	0
Depreciation	0	0	1	1	3	4
Income Before Tax	-8	20	-17	-18	-42	-34
Income Tax Expense	0	0	0	0	0	-
Net Income	-8	20	-17	-18	-42	-34
Net Profit Margin	-261.07%	36.42%	-28.16%	-78.40%	-1884.50%	-2579.80%

Sab Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-6	-5	-22	-5	-7	-10	-11	-5	-13
Operating Cash Flow	-4	-5	-13	-10	-7	-6	-9	-7	-7
Investing Cash Flow	0	0	0	-31	11	-1	9	4	5
Financing Cash Flow	0	0	67	0	0	0	0	0	0
Change in Cash	-5	-5	54	-42	3	-8	0	-3	2

Sab Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	20	-17	-17	-42	-34
Operating Cash Flow	10	3	3	-25	-34
Investing Cash Flow	-12	-10	-10	0	-11
Financing Cash Flow	8	34	1	66	-1
Change in Cash	6	26	26	41	-47

Global Institutional Holdings in Sab Biotherapeutics Inc

Funds	Holdings
Bvf Inc	9.88%
Sessa Capital IM LP	4.94%
Vanguard Group Inc	2.99%
Geode Capital Management, LLC	0.91%
Pathstone Holdings LLC	0.55%

See all

Insights on Sab Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 6 months, SABS stock has moved up by 38.7%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, -410.0 → 114.69K (in $), with an average increase of 100.4% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 84.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 191.5%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -5.19M → -10.11M (in $), with an average decrease of 94.6% per quarter

About Sab Biotherapeutics Inc

sab biotherapeutics is a clinical-stage biopharmaceutical development company using its novel immunotherapy platform to produce life-saving therapies.

Organisation	Sab Biotherapeutics Inc
Headquarters	777 W 41st St., Miami Beach, FL, United States, 33140
CEO	Mr. Samuel J. Reich
E-voting on shares	Click here to vote

Key Management of Sab Biotherapeutics Inc

Name	Title
Ms. Kaelan Hollon J.D.	Vice President of Communications
Ms. Catherine DeRose	Vice President of Human Resources
Mr. Samuel J. Reich	CEO & Executive Chairman
Ms. Christine E. Hamilton M.B.A.	Co-Founder & Independent Director
Dr. Alexandra Kropotova M.B.A., M.D.	Executive VP & Chief Medical Officer
Dr. Edward D. Hamilton D.V.M.	Co-Founder & Board Observer
Dr. Eddie Joe Sullivan Ph.D.	Co-Founder, President & Director
Ms. Lucy To	Executive VP & CFO
Dr. Christoph Bausch M.B.A., Ph.D.	Executive VP & COO
Ms. Hua Wu Ph.D.	Senior Vice President of Product Development

FAQs

What is Sab Biotherapeutics Inc share price today?

Sab Biotherapeutics Inc share price today is $2.58 as on September 18, 2025 at 1:29 am IST at the close of the market. Sab Biotherapeutics Inc share today touched a day high of $2.63 and a low of $2.19.

What is the 52 week high and 52 week low for Sab Biotherapeutics Inc share?

Sab Biotherapeutics Inc share touched a 52 week high of $6.6 on July 21, 2025 and a 52 week low of $1 on April 4, 2025. Sab Biotherapeutics Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $2.58,which is 60.91% down from its 52 week high and 158.00% up from its 52 week low.

What is Sab Biotherapeutics Inc's market capitalisation today?

Sab Biotherapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Sab Biotherapeutics Inc Stock (SABS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Sab Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sab Biotherapeutics Inc Shares that will get you 0.5814 shares as per Sab Biotherapeutics Inc share price of $2.58 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Sab Biotherapeutics Inc Stock (SABS) from India?

Indian investors can start investing in Sab Biotherapeutics Inc (SABS) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 11:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Sab Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 11:39 am IST). Based on Sab Biotherapeutics Inc share’s latest price of $2.58 as on September 18, 2025 at 1:29 am IST, you will get 3.8760 shares of Sab Biotherapeutics Inc. Learn more about fractional shares .